Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022

Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022

Background: Adoption of neoadjuvant chemotherapy (NACT) in the “real world” has been poorly investigated. Aim of this study was to examine the rate of NACT in Italy, trends over time and determinants of therapeutic choices. Methods: Senonetwork, the recognized network of Breast Centers in Italy, has...

Full description

Saved in:
Bibliographic Details
Main Authors: A. De Luca, M.I. Amabile, F. Santori, S. Di Matteo, M. Tomatis, A. Ponti, F. Frusone, M. Taffurelli, C. Tinterri, L. Marotti, M. Calabrese, C. Marchiò, F. Puglisi, I. Palumbo, L. Fortunato
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Breast
Subjects:
Breast cancer
Neoadiuvant chemotherapy
Breast centers
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977624001218
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S0960977624001218

Similar Items